INCE

2025.02.17

Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases

2022.01.29

INCE Capital Participates in PONHU’s $45 Million Series C+ Funding

2021.12.07

Baby Food Brand Qiutianmanman Receives Series B Financing Led by INCE

2021.09.21

BEASTER Completed INCE-led First-round Financing of Over RMB 200 Million

2021.08.24

INCE Capital Continued to Invest in PETKIT’s D Round of Financing, Which Closed $50m

2021.08.24

PatPat, a Portfolio Company of INCE Capital, Announced the Completion of the D2 Round of Financing, Which Closed $160m

2021.08.12

Yuanxin Technology has Completed its F Round of Financing Totaling over 1.5b Yuan, with Continued Investment from INCE Capital

2021.08.11

INCE Capital Led Financing in Collectible Toy Brand ToyCity’s A+ Round of Financing

2021.07.22

PatPat Closed Series C and Series D Funding at $510 Million, with Investment from INCE Capital

2021.06.21

Ponhu Luxury Closed Series C Funding at Approximately $50 Million, with Continued Investment from INCE Capital